A series of O56-substituted carboxyester or carboxyamide derivatives of deglucoteicoplanin (TD) was prepared by condensation of the 56-hydroxyl function with various alkylating agents of general formula RBr, where R represents functional groups with different physico-chemical properties.
The activity of the new compoundsdid not show any significant improvement whencompared withTD.
The physico-chemical and antibacterial properties of the synthesized compounds are reported.
Teicoplanin,1^which recently became available for therapeutic uses, is a glycopeptide antibiotic suitable for treatment of severe Gram-positive infections. 4'5) The mechanismof action of teicoplanin is similar to that of other glycopeptide antibiotics. It binds strongly to the terminal D-alanyl-D-alanine of the muramylpentapeptide during the biosynthesis of bacterial cell wall peptidoglycan. 2' 6) The chemical work on teicoplanin complex (CTA) and on derivatives obtained from partial or total hydrolysis of the glycosidic bonds (TB, TC and TD, see Fig. 1 ),7'8) coupled with in vitro binding assays,9) has indicated which functional groups of teicoplanin are important in the binding to the target. Other parts of the antibiotic, such as the carboxyl in position 63,1O~12) can be modified to obtain compounds with different physico-chemical properties, and possibly better antimicrobial activity, without affecting the binding strength.
The chemical derivatizations carried out in the past were mainly directed toward broadening the antibacterial spectrum of activity of teicoplanin (in particular against Gram-negative bacteria and coagulase-negative staphylococci) and toward the preparation of orally active derivatives. 10~12) The product obtained from total glycosidic hydrolysis of teicoplanin, deglucoteicoplanin (TD), shows somein vitro activity against Gram-negative bacteria7) that are not sensitive to teicoplanin. However,TD has poor efficacy as compared with teicoplanin (CTA) in experimental infections.
3) The acylglucosamine in position 56 of CTAthus appears to be important for in vivo activity of the molecule while its removal (together with the other sugars) increases penetration into Gram-negative bacteria.
We decided to explore the influence of various substituent introduced in position 56 ( Fig. 1 ) replacing the acylglucosamine moiety of the natural antibiotic. Wethought that these modifications might produce aglycone derivatives having favourable physico-chemical properties and, consequently, improved as benzyl carbamate (CBz) 2 and deprotection of intermediates 9~12 by catalytic hydrogenation.
In Scheme2 the synthesis of substituted CMEcompoundscontaining alkylamino chains in 56 is reported: 18 from ll by reaction with ethylenediamine through intermediate 17; 19 from 14 after hydrolysis of the phthalimido group with hydrazine hydrate; 22 from 10 after hydrolysis of the phthalimido group Compoundsbearing 63-esters other than methyl were also prepared; in Scheme 7 shows the preparation of two simple 56-substituted carboxy TDcompoundsby alkylation of 1 (54) or hydrogenolysis of 49 (55).
All 25 final products are listed in Table 1 together with some of their properties; NMRdata of significant protons are reported in Table 2 . For the spectrum of TDcore structure see ref 7 .
All the reactions were monitored by HPLCand the products were characterized by HPLC, IR, MS and NMR(see the Experimental for details).
Results and Discussion Table 3 shows the in vitro antibacterial activity of all the O-56 substituted derivatives that were 4-Aminobutyl 
synthesized in comparison with TD.
The antibacterial activity of these derivatives is generally good against streptococci, while it goes from moderate to good against staphylococci and against Enterococcus faecalis. No one among them showed any improvementin in vitro activity when comparedwith TD. Somestructure-activity relationships can be extracted from the examination of these data. Bulky esters in position 63 (benzyl, butyrolactone) caused the changing from good to moderate activity against staphylococci and enterococci; bulky groups in position 56 (phthalimidobutyl) caused a similar effect in antibacterial activity on staphylococci and enterococci; a basic chain in position 56 (pyrrolidine, ethylenediamine, aminobutyl) produced derivatives with good antimicrobial activity.
The binding constants for D-Ala-D-Ala, determined for some of the derivatives bearing different functional groups in position 56, resulted to be similar among basic (pyrrolidine, morpholine) and neutral (hydroxyl, chloro) 56-substituents ( All compounds were analyzed for C, H, N and Cl using samples dried at 140°C under N2 atmosphere. Weight loss was determined after heating the sample at 900°C in O2 atmosphere. The analytical results were in accordance with theoretical values.
IR spectra (nujol) were recorded with a Perkin-Elmer 850 spectrometer.
*H and 13C NMRspectra were obtained at 250MHzwith a Bruker AM250 instrument equipped with an Aspect 3000 console. The spectra were recorded at 40°C in deuterated DMSO solution using tetramethylsilane (TMS, 0.00 ppm) as internal reference.
FAB-MSpositive ion spectra were obtained on a Kratos MS-50instrument fitted with a standard FABsource and a high-field magnet; the sample (10 micromoles) was dispersed in a few microliters of 2-thioglycerol-diglycerol (1 : 1) matrix and bombarded with a 6~9keV beam of Xe atoms. Binding constants of peptide to teicoplanin aglycone or its derivatives were measured essentially as described by Nieto and Perkins9) except that tandem arrangement of cuvettes was not required, since the peptide used in this work has no significant absorption in the range 250~340nm.Experiments were carried out with a Perkin-Elmer 580 spectrophotometer, using cuvettes with 4-cm light path. Solutions (10ml) containing antibiotic (25/an in 10% methanol: 90% 0.02m sodium citrate, pH 5) were placed in the sample and reference cuvettes, and the difference in absorbance that developed upon addition of Ac-D-Ala-D-Ala (10~50/d of 4mMsolution) to the sample cuvette and the same volume of buffer to the reference cuvette was measured at 282~285 nm. The temperature was 31°C. Association constants were determined by Scatchard plots. The antibiotic concentrations were determined by UVabsorption, with the extinction coefficient of teicoplanin at 279 nm(El cm= 59.4) as reference.13) The peptide titer was first determined in distilled water by potentiometric titration, and then the desired concentration was prepared by dilution.
MIC were determined using the microbroth dilution method. The media used were: Todd-Hewitt broth (Difco) for streptococci; Iso-Sensitest broth (Oxoid) for staphylococci, E. faecalis, Escherichia coli, Proteus vulgaris and Pseudomonas aeruginosa; GCbase broth (Difco)+ 1% v/v BBLIsovitalex for Neisseria gonorrhoeae; brain-heart infusion broth (Difco) 4-1 % v/v Difco supplement C for Haemophilus influenzae. The inoculum was about 104cfu/ml. Incubation was at 37°C in 5% CO2for 48 hours for N. gonorrhoeae and H. influenzae, in air for 18~24 hours for other species.
O-56-(2-Hydroxyethyl) TD Methyl Ester (7) OCT. 1992
To a solution of 3n) (2g, 1.52mmol) in 80ml of DMSOcontaining K2CO3 (414mg, 3mmol) and molecular sieves 4A (3g), 2-bromoethanol (0.6ml, 7 mmol) was added and the mixture stirred at room temperature for 6 hours. A second portion of 2-bromoethanol was added and the reaction was allowed to stand overnight at room temperature. The mixture was then diluted with 400ml of water and the suspension, adjusted to pH 4 with 1 n HC1, was extracted with 200ml of ethyl acetate-rc-butanol 4 : 1. The organic layer was concentrated in vacuo and the residue was purified on a silica gel column(130g) eluting with a mixture methylene chloride-methanol 9 : 1 yielding 1.04g of compound 5. The protecting group was removed by treatment of 5 with TFA(3ml) for 15 minutes. After concentration in vacuo, purification of the crude material was done on a silanized silica gel column, eluting with acetonitrile -water 15 : 85 and obtaining 550mg of pure title compound.
N-15-CBz TD Methyl Ester (8) Starting from 211} and using substantially the same esterification procedure described for 311} 35 g of pure title compoundwere obtained.
O-56-(4-(7V-Phthalimido)-butyl)TD
Methyl Ester Hydrochloride (14) The reaction between 8 (2 g, 1.48 mmol) and 7V-(4-bromobutyl) phthalimide (420mg, 1.48 mmol) was performed as for compound 5 producing 1 g of pure intermediate 10. This product was dissolved in 80ml of MeOHcontaining 1 ml of 1 n HC1 and hydrogenated with 5% Pd/C (400mg) at room temperature and atmospheric pressure. The catalyst was filtered on filter aid (Celite), the solvent was removed in vacuo from the filtrate and the solid was treated with ethyl ether, collected by filtration and dried, yielding 860 mg of pure title compound.
O-56-(4-Aminobutyl)
TD Methyl Ester Dihydrochloride (19) Compound 14 (800mg, 0.56mmol) was dissolved in a mixture of absolute ethanol (80ml) and acetonitrile (20ml), then 0.5 ml of hydrazine hydrate were added and the reaction was stirred overnight at room temperature. The solvents were removedin vacuo and the resulting crude material was purified on a silanized silica gel column (60 g) eluting first the impurities with a gradient from 35 to 45% of MeCN in water (600ml), then the desired product with 300ml of MeOHcontaining 1% of 1 n HC1. The pooled fractions were concentrated to dryness yielding 260 mg of pure title compound.
TD Methyl Ester (12) Intermediate 8 (6g, 4.4mmol) was dissolved in DMSO(60ml) and K2CO3 (620mg, 4.5mmol) was added while stirring the mixture at 40°C for 15 minutes; 1.5 ml (17 mmol) of 1,2-dibromoethane were then added. The mixture was stirred at 40°C for 4 hours and overnnight at room temperature, then it was diluted with 400ml of water, adjusted to pH 5 with 1 n HC1; the resulting suspension was centrifuged. The solid was recovered, washed with water and dried in vacuo at 40°C, yielding 6 g of pure title compound.
O-56-(2-(l-Pyrrolidinyl)-ethyl)TD
Methyl Ester Dihydrochloride (25) 700mg (0.5mmol) of 12 were dissolved in absolute ethanol (40ml) and DMSO(20ml); pyrrolidine (0.7ml, 8.4mmol) was added and the solution was heated at 50°C for 8 hours. The mixture was then poured into 300ml of chilled water and the solid was recovered by centrifugation. The solid was dissolved in 40ml of 30% THF in water at pH 6.5 (1n HC1) and loaded onto a silanized silica gel column; it was eluted using MeCN-water 3 : 7 producing 400mg of compound 23. Deprotection in MeOH(45ml) and 0.1 n HC1(15ml) with 5% Pd/C for 3 hours produced 280mg of pure title compound.
N-1 5-Boc TD Ethylenediamine Amide (33)
Compound 2712) (2g, 1.6mmol) was reacted at room temperature with a strong excess of ethylenediamine for 2 hours in 200ml of absolute ethanol; after cooling, the solution was concentrated to a crude material that was chrornatographed with a reversed phase silica gel column, eluting with a gradient of 20 to 50% of MeCNin water. After concentration to dryness of the pooled fractions, 1.4g of pure title compoundwere obtained. in DMF(30ml) with TEA (0.6ml); after purification on a silanized silica gel column, pure protected compound (2 g) was obtained. This compound was reacted with 1,2-dibromoethane (0.425 ml) in DMSO(17ml) in the presence of K2CO3(175 mg); after 16 hours at room temperature a second portion of 1,2-dibromoethane (0.45ml) was added with K2CO3 (200 mg) and the reaction was stirred for 12 hours. The mixture was then poured into chilled water (300 ml), the pH adjusted to 5, and the product recovered by centrifugation.
This material was dissolved in 200ml of ethyl acetate, washed with water, and the solvent was removed in vacuo. The residue was dissolved in n-butanol and the mixture was concentrated under vacuumto a final volumeof 5ml. Ethyl ether was added (400ml) and the solid was recovered by filtration, yielding an intermediate from which crude 34 was prepared following the procedure used for compound 23 just replacing pyrrolidine with ethylenediamine (1.5 g). It was purified on a silanized silica gel column, eluting with MeCN-water 3 : 7 with a pH gradient of 0 to 1.5% of 1 n HC1, obtaining 650mg of pure intermediate 34. This was fully deprotected following the procedure used for 7 yielding 500mg of pure title compound.
N-15-Boc TD 2-Bromoethyl Ester (36)
To a solution of ln) (5g, 3.87mmol) in 50ml of DMSO, KHCO3 (500mg, 5mmol) and 1 ,2-dibromoethane (5 ml, 58 mmol) were added with stirring at room temperature. After 2 hours the reaction mixture was poured into water (500 ml), the pH was adjusted to 5 and the precipitate was filtered, washed with water and collected as a crude material. It was then purified on a reverse-phase chromatographic column eluting with a gradient of 10 to 50% of MeCNin water at about pH 3 (1 n HC1) obtaining 4.85g of pure title compound.
To a solution of 36 (5g, 3.56mmol) in 50ml of DMSO, K2CO3 (550mg, 4mmol) and 1,2-dibromoethane (5 ml, 58 mmol) were added with stirring and the resulting solution was heated at 50°C for 2 hours. After cooling, it was poured into 300ml of water, the pH was adjusted to about 6 and the precipitate was filtered, washed with water and dried obtaining 5.47 g of intermediate 37. To a solution of 37 (I g, 0.66mmol) in 10ml of DMSO, K2CO3 (220mg, 1.6mmol) and glycylglycine methyl ester hydrochloride (260mg, 1 mmol) were added with stirring and the solution was kept at 40°C for 6 hours. After cooling, the mixture was poured into 50ml of water, adjusting the pH to 6; the precipitate was filtered, washed with water and dried obtaining 0.93 g of intermediate 39 which was deprotected as for compound 7 to give 0.52g of pure title compound. a-bromo-y-butyrolactone (2ml, 24mmol) were added with stirring and the mixture was kept at 50°C for 2 hours. After a workup similar to that used for 39, 2.07 g of compound46 were obtained and deprotected as for 7 to give 1.66g of pure title compound.
O-56-(Tetrahydro-2-oxo-3-furanyl) TD Tetrahydro-2-oxo-3-furanyl Ester (51) To a solution of 1 (5g, 3.87mmol) in 50ml of DMSO,K2CO3(1.1g, 8mmol) was added with a-bromo-y-butyrolactone (10ml, 120mmol) with stirring and kept for 3 hours at 40°C. After a workup as for 39 5.76g of intermediate 50 were obtained. It was then treated as described for 7 obtaining 4.14g of pure title compound.
O-56-(( l -(2-Aminoethyl)amino)carbonyl-3-hydroxypropyl) TD (l -(2-Aminoethyl)amino)carbonyl-3-hydroxypropyl Ester (52) To a solution of 51 (1g, 0.731mmol) in 10ml of DMSO, ethylenediamine was added (0.25ml, OCT. 1992 3.74mmol) with stirring at room temperature. After an hour a workup as for 39 followed, giving 0.86g of pure title compound.
O-56-(Tetrahydro-2-oxo-3-furanyl) TD (55) A solution of 100mg of49 (0.078mmol) in 10ml of MeOH-water7:3 adjusted to pH 3 with In HC1was hydrogenated at room temperature and atmospheric pressure with 50mgof 5% Pd/C for 2 hours with vigorous stirring. Then the pH was djusted to about 6 and the MeOHremoved in vacuo. The resulting suspension was centrifuged and the solid, collected by filtration, was washed with water and dried giving 55 mg of pure title compound.
